 DURHAM, N.C., Oct. 27, 2022 GLOBE NEWSWIRE -- Chimerix NASDAQ:CMRX, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Thursday, November 3, 2022 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2022, and to provide a business overview. 